As of 2025-06-22, the EV/EBITDA ratio of Oramed Pharmaceuticals Inc (ORMP) is -0.97. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ORMP's latest enterprise value is 12.49 mil USD. ORMP's TTM EBITDA according to its financial statements is -12.85 mil USD. Dividing these 2 quantities gives us the above ORMP EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-06-12 | -1.26 |
| 2025-06-11 | -1.29 |
| 2025-06-10 | -1.29 |
| 2025-06-09 | -1.29 |
| 2025-06-06 | -1.26 |
| 2025-06-05 | -1.04 |
| 2025-06-04 | -1.45 |
| 2025-06-03 | -1.39 |
| 2025-06-02 | -1.77 |
| 2025-05-30 | -1.64 |
| 2025-05-29 | -1.29 |
| 2025-05-28 | -1.07 |
| 2025-05-27 | -1.00 |
| 2025-05-23 | -0.94 |
| 2025-05-22 | -1.04 |
| 2025-05-21 | -0.91 |
| 2025-05-20 | -1.04 |
| 2025-05-19 | -1.00 |
| 2025-05-16 | -1.04 |
| 2025-05-15 | -1.20 |
| 2025-05-14 | -1.23 |
| 2025-05-13 | -1.32 |
| 2025-05-12 | -1.32 |
| 2025-05-09 | -1.35 |
| 2025-05-08 | -1.48 |
| 2025-05-07 | -1.26 |
| 2025-05-06 | -1.29 |
| 2025-05-05 | -1.55 |
| 2025-05-02 | -1.58 |
| 2025-05-01 | -1.42 |
| 2025-04-30 | -1.58 |
| 2025-04-29 | -1.61 |
| 2025-04-28 | -1.32 |
| 2025-04-25 | -1.61 |
| 2025-04-24 | -1.51 |
| 2025-04-23 | -1.55 |
| 2025-04-22 | -1.48 |
| 2025-04-21 | -1.35 |
| 2025-04-17 | -1.04 |
| 2025-04-16 | -1.20 |
| 2025-04-15 | -1.29 |
| 2025-04-14 | -1.42 |
| 2025-04-11 | -0.91 |
| 2025-04-10 | -0.97 |
| 2025-04-09 | -0.94 |
| 2025-04-08 | -0.65 |
| 2025-04-07 | -0.88 |
| 2025-04-04 | -0.88 |
| 2025-04-03 | -1.07 |
| 2025-04-02 | -1.20 |